Cipla advances on receiving potential investment from FIL Capital for its WOS

21 Jul 2015 Evaluate

Cipla is currently trading at Rs. 685.95, up by 3.00 points or 0.44% from its previous closing of Rs. 682.95 on the BSE.

The scrip opened at Rs. 683.10 and has touched a high and low of Rs. 687.60 and Rs. 680.00 respectively. So far 11,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 752.45 on 10-Mar-2015 and a 52 week low of Rs. 430.35 on 08-Aug-2014.

Last one week high and low of the scrip stood at Rs. 691.50 and Rs. 663.60 respectively. The current market cap of the company is Rs. 55,088.00 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 35.18% and 25.83% respectively.

Cipla has received an approval to accept a potential investment by FIL Capital Investments (Mauritius) II, or any of its affiliate in a wholly owned subsidiary (WOS) of the company (proposed to be incorporated) to whom Cipla will be divesting its consumer healthcare business on a going-concern basis.

The board of directors at their meeting held on July 20, 2015 has approved for the same. The approval is subject to execution of binding agreements, and the transaction will be subject to relevant regulatory approvals.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.


Cipla Share Price

1491.40 -3.00 (-0.20%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×